Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12414995 | Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer | Yong Wan, Zhuan Zhou, Junlong Chi | 2025-09-16 |
| 12311029 | Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein | Derek A. Wainwright | 2025-05-27 |
| 12252492 | Substituted fused pyrrolo-diazepinones and uses thereof | Karl A. Scheidt | 2025-03-18 |
| 12152007 | Substituted heterocycles as c-MYC targeting agents | Rama K. Mishra, Huiying Han, Sarki A. Abdulkadir, Javier Izquierdo-Ferrer, Atul D. Jain | 2024-11-26 |
| 12042543 | Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2 | Jindan Yu | 2024-07-23 |
| 11981678 | Substituted [1,2,4]triazolo[4,3-c]pyrimidin-5-amines and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of embryonic ectoderm development (EED) protein | Jindan Yu | 2024-05-14 |
| 11919855 | Substituted pyrrolidones and piperidones as small molecule inhibitors of EZH2 and EED protein binding | Jindan Yu | 2024-03-05 |
| 11890346 | Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-MYC protein | Atul D. Jain, Huiying Han, Sarki A. Abdulkadir | 2024-02-06 |
| 11839659 | Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of indoleamine 2,3-dioxygenase (IDO) protein | Derek A. Wainwright | 2023-12-12 |
| 11453640 | Small molecules for disrupting the super elongation complex and inhibiting transcription elongation for cancer therapy | Ali Shilatifard, Kaiwei Liang, Edwin Richard Smith, Rama K. Mishra, Kristen Stoltz | 2022-09-27 |
| 11420957 | Substituted heterocycles as c-MYC targeting agents | Atul D. Jain, Huiying Han, Sarki A. Abdulkadir | 2022-08-23 |
| 11370770 | 3-arylindazoles as selective MEK4 inhibitors | Karl A. Scheidt, Matthew R. Clutter, Ada J. Kwong | 2022-06-28 |
| 11225483 | Substituted fused pyrrolo-diazepinones and uses thereof | Karl A. Scheidt | 2022-01-18 |
| 11142504 | Substituted heterocycles as c-MYC targeting agents | Rama K. Mishra, Huiying Han, Sarki A. Abdulkadir, Javier Izquierdo-Ferrer, Atul D. Jain | 2021-10-12 |
| 10851082 | Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2) | Javier Izquierdo-Ferrer, Purav Vagadia, Matthew R. Clutter, Rama K. Mishra, Leonidas C. Platanias | 2020-12-01 |
| 10640502 | Therapeutic targeting of interleukin-1 receptor-associated kinase 4 (IRAK4) in cancers characterized by rearrangements in the mixed lineage leukemia gene (MLL-r) | Ali Shilatifard, Kaiwei Liang, Edwin Richard Smith | 2020-05-05 |
| 10435375 | CXCR4 chemokine receptor modulators | Richard Jonathan Miller, Rama K. Mishra | 2019-10-08 |
| 10093668 | Substituted aromatic N-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (Mnk1) and 2 (Mnk2) | Rama K. Mishra, Leonidas C. Platanias, Javier Izquierdo-Ferrer | 2018-10-09 |
| 9981968 | Substituted pyrrolo[2,3-d]pyrimidines for the treatment of cancer and proliferative disorders | Karl A. Scheidt, Steven T. Rosen, Nancy L. Krett | 2018-05-29 |
| 9688637 | 3-amidobenzamides and uses thereof for increasing cellular levels of A3G and other A3 family members | Chisu Song, Richard T. D'Aquila, Meejeon Roh | 2017-06-27 |
| 9669014 | Small molecule inhibitors of superoxide dismutase expression | Teepu Siddique, Thomas J. Lukas, Hasan Arrat | 2017-06-06 |
| 8791267 | Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders | Jasbir Singh, Mark E. Gurney, Alex Burgin, Vincent P. Sandanayaka, Alexander Kiselyov +3 more | 2014-07-29 |